Trials / Completed
CompletedNCT06520371
Percutaneous vs Conventional Radiofrequency Applications for the Treatment of Knee Osteoarthritic Pain
Comparison of Percutaneous and Conventional Radiofrequency Applications for the Treatment of Knee Osteoarthritic Pain: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare percutaneous and conventional radiofrequency applications for the treatment of knee osteoarthritic pain.
Detailed description
Osteoarthritis (OA) is a progressive degenerative joint disease that affects the joint cartilage and surrounding tissues. It mostly affects the weight-bearing joints, and in this respect, the knee joint is one of the joints that is most affected. Radiofrequency (RF) treatment has been used for several painful conditions such as trigeminal neuralgia, cancer pain, and spinal pain. To destroy nerves or disrupt the transmission of pain signals, originally using producing heat lesions, RF current is applied to the trigeminal ganglion, the spinothalamic tracts of the spinal cord, the medial branches of posterior rami, and the dorsal root ganglion. In addition to these, there have been a few attempts to apply RF current for the treatment of painful conditions of joints of the extremities. Percutaneous radiofrequency ablation (RFA) of articular sensory nerves has recently emerged as an attractive and minimally invasive approach to treat chronic pain due to large-joint osteoarthritis in select patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous radiofrequency | For the percutaneous radiofrequency treatment, a medium electrode size will be placed on either side of the knee: one skin electrode on the inside and one on the outside of the knee for 15 minutes. |
| DEVICE | Conventional radiofrequency | For the conventional radiofrequency treatment, a 50 Hz sensory stimulation will be performed with a 10 cm, 22 gauge, 10 mm active tip radiofrequency cannula. After receiving the appropriate sensory and motor stimuli, a radiofrequency of 90°C will be applied for 90 s. |
Timeline
- Start date
- 2024-07-25
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-07-25
- Last updated
- 2025-01-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06520371. Inclusion in this directory is not an endorsement.